Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00022048
What this trial is testing

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Stanford University
Post-approval studies (Phase 4)UnknownNCT03999125
What this trial is testing

Anti-VEGF Therapy Versus Dexamethasone Implant for DME

Who this might be right for
Clinically Significant Macular Edema Due to Diabetes Mellitus
Sudhalkar Eye Hospital 150
Post-approval studies (Phase 4)UnknownNCT01857544
What this trial is testing

Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

Who this might be right for
Retinal Vein Occlusion
Tennessee Retina 10
Testing effectiveness (Phase 2)Study completedNCT00113230
What this trial is testing

Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer

Who this might be right for
Rectal Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05247684
What this trial is testing

AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC

Who this might be right for
Resectable Non-small Cell Lung Cancer
Akeso 90
Not applicableLooking for participantsNCT05108519
What this trial is testing

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 170
Testing effectiveness (Phase 2)Study completedNCT01621568
What this trial is testing

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

Who this might be right for
ThymomaThymus Neoplasms
National Cancer Institute (NCI) 56
Not applicableStudy completedNCT01644513
What this trial is testing

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients

Who this might be right for
Age Related Macular Degeneration
Sequenom, Inc. 196
Post-approval studies (Phase 4)Study completedNCT01223612
What this trial is testing

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation

Who this might be right for
Diabetic Retinopathy
Moorfields Eye Hospital NHS Foundation Trust 37
Not applicableUnknownNCT04627402
What this trial is testing

Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)

Who this might be right for
Diabetes Mellitus, Type 2Macular Edema
Zhongshan Ophthalmic Center, Sun Yat-sen University 50
Not applicableEnrolling By InvitationNCT07338097
What this trial is testing

Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema (DME)
CMH Multan Institute of Medical Sciences 116
Testing effectiveness (Phase 2)Looking for participantsNCT07111520
What this trial is testing

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
BioNTech SE 880
Post-approval studies (Phase 4)Ended earlyNCT04563299
What this trial is testing

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Retina Vitreous Associates of Florida 10
Testing effectiveness (Phase 2)Study completedNCT00022659
What this trial is testing

Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage IV Ovarian Epithelial Cancer
National Cancer Institute (NCI) 64
Large-scale testing (Phase 3)UnknownNCT03794440
What this trial is testing

Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Innovent Biologics (Suzhou) Co. Ltd. 595
Large-scale testing (Phase 3)Study completedNCT01223027
What this trial is testing

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 564
Testing effectiveness (Phase 2)Study completedNCT00775411
What this trial is testing

Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 44
Testing effectiveness (Phase 2)Looking for participantsNCT07587515
What this trial is testing

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Eyconis INC. 30
Not applicableLooking for participantsNCT06537908
What this trial is testing

Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 50
Early research (Phase 1)Study completedNCT01579760
What this trial is testing

Intravitreal Aflibercept Injection for Radiation Retinopathy

Who this might be right for
Radiation RetinopathyMacular Edema
Washington University School of Medicine 9
Next Page